Kuan Yan, Yue Zeng, Dai Shi, Ting Zhang, Dmytro Matsypura, Mark C. Gillies, Ling Zhu, Junbin Gao
{"title":"基于机器学习预测与年龄相关性黄斑变性小鼠模型中视网膜下病变严重程度相关的关键基因","authors":"Kuan Yan, Yue Zeng, Dai Shi, Ting Zhang, Dmytro Matsypura, Mark C. Gillies, Ling Zhu, Junbin Gao","doi":"arxiv-2409.05047","DOIUrl":null,"url":null,"abstract":"Age-related macular degeneration (AMD) is a major cause of blindness in older\nadults, severely affecting vision and quality of life. Despite advances in\nunderstanding AMD, the molecular factors driving the severity of subretinal\nscarring (fibrosis) remain elusive, hampering the development of effective\ntherapies. This study introduces a machine learning-based framework to predict\nkey genes that are strongly correlated with lesion severity and to identify\npotential therapeutic targets to prevent subretinal fibrosis in AMD. Using an\noriginal RNA sequencing (RNA-seq) dataset from the diseased retinas of JR5558\nmice, we developed a novel and specific feature engineering technique,\nincluding pathway-based dimensionality reduction and gene-based feature\nexpansion, to enhance prediction accuracy. Two iterative experiments were\nconducted by leveraging Ridge and ElasticNet regression models to assess\nbiological relevance and gene impact. The results highlight the biological\nsignificance of several key genes and demonstrate the framework's effectiveness\nin identifying novel therapeutic targets. The key findings provide valuable\ninsights for advancing drug discovery efforts and improving treatment\nstrategies for AMD, with the potential to enhance patient outcomes by targeting\nthe underlying genetic mechanisms of subretinal lesion development.","PeriodicalId":501070,"journal":{"name":"arXiv - QuanBio - Genomics","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Machine Learning-Based Prediction of Key Genes Correlated to the Subretinal Lesion Severity in a Mouse Model of Age-Related Macular Degeneration\",\"authors\":\"Kuan Yan, Yue Zeng, Dai Shi, Ting Zhang, Dmytro Matsypura, Mark C. Gillies, Ling Zhu, Junbin Gao\",\"doi\":\"arxiv-2409.05047\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Age-related macular degeneration (AMD) is a major cause of blindness in older\\nadults, severely affecting vision and quality of life. Despite advances in\\nunderstanding AMD, the molecular factors driving the severity of subretinal\\nscarring (fibrosis) remain elusive, hampering the development of effective\\ntherapies. This study introduces a machine learning-based framework to predict\\nkey genes that are strongly correlated with lesion severity and to identify\\npotential therapeutic targets to prevent subretinal fibrosis in AMD. Using an\\noriginal RNA sequencing (RNA-seq) dataset from the diseased retinas of JR5558\\nmice, we developed a novel and specific feature engineering technique,\\nincluding pathway-based dimensionality reduction and gene-based feature\\nexpansion, to enhance prediction accuracy. Two iterative experiments were\\nconducted by leveraging Ridge and ElasticNet regression models to assess\\nbiological relevance and gene impact. The results highlight the biological\\nsignificance of several key genes and demonstrate the framework's effectiveness\\nin identifying novel therapeutic targets. The key findings provide valuable\\ninsights for advancing drug discovery efforts and improving treatment\\nstrategies for AMD, with the potential to enhance patient outcomes by targeting\\nthe underlying genetic mechanisms of subretinal lesion development.\",\"PeriodicalId\":501070,\"journal\":{\"name\":\"arXiv - QuanBio - Genomics\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"arXiv - QuanBio - Genomics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/arxiv-2409.05047\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"arXiv - QuanBio - Genomics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/arxiv-2409.05047","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Machine Learning-Based Prediction of Key Genes Correlated to the Subretinal Lesion Severity in a Mouse Model of Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is a major cause of blindness in older
adults, severely affecting vision and quality of life. Despite advances in
understanding AMD, the molecular factors driving the severity of subretinal
scarring (fibrosis) remain elusive, hampering the development of effective
therapies. This study introduces a machine learning-based framework to predict
key genes that are strongly correlated with lesion severity and to identify
potential therapeutic targets to prevent subretinal fibrosis in AMD. Using an
original RNA sequencing (RNA-seq) dataset from the diseased retinas of JR5558
mice, we developed a novel and specific feature engineering technique,
including pathway-based dimensionality reduction and gene-based feature
expansion, to enhance prediction accuracy. Two iterative experiments were
conducted by leveraging Ridge and ElasticNet regression models to assess
biological relevance and gene impact. The results highlight the biological
significance of several key genes and demonstrate the framework's effectiveness
in identifying novel therapeutic targets. The key findings provide valuable
insights for advancing drug discovery efforts and improving treatment
strategies for AMD, with the potential to enhance patient outcomes by targeting
the underlying genetic mechanisms of subretinal lesion development.